Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 1, Pages 9
Publisher
MDPI AG
Online
2018-12-31
DOI
10.3390/pharmaceutics11010009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
- (2018) Chi Ming Laurence Lau et al. ADVANCED DRUG DELIVERY REVIEWS
- Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
- (2018) Jean Kim et al. JOURNAL OF CONTROLLED RELEASE
- Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways
- (2018) Marko Lamminsalo et al. PHARMACEUTICAL RESEARCH
- In Vivo Stability Profiles of Anti-factor D Molecules Support Long-Acting Delivery Approaches
- (2018) Kelly M. Loyet et al. MOLECULAR PHARMACEUTICS
- Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye
- (2017) Devin Tesar et al. mAbs
- Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model
- (2017) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetic aspects of retinal drug delivery
- (2017) Eva M. del Amo et al. PROGRESS IN RETINAL AND EYE RESEARCH
- A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration
- (2016) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab
- (2016) Whitney Shatz et al. MOLECULAR PHARMACEUTICS
- Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development
- (2015) Eva M. del Amo et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Simulating Intravitreal Injections in Anatomically Accurate Models for Rabbit, Monkey, and Human Eyes
- (2012) Paul J. Missel PHARMACEUTICAL RESEARCH
- Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit
- (2011) Hong Li et al. EXPERIMENTAL EYE RESEARCH
- Barrier analysis of periocular drug delivery to the posterior segment
- (2010) Veli-Pekka Ranta et al. JOURNAL OF CONTROLLED RELEASE
- VEGF inhibitors for the treatment of neovascular age-related macular degeneration
- (2009) Mark Rami Barakat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Multicenter study of compliance and drop administration in glaucoma
- (2008) Ramin Kholdebarin et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started